Recurrence-Free Survival of a Hepatocellular Carcinoma Patient With Tumor Thrombosis of the Inferior Vena Cava After Treatment With Sorafenib and Hepatic Resection

Sorafenib (Nexabar, Bayer, Berlin, Germany), one of multikinase inhibitors, can infrequently downstage advanced hepatocellular carcinoma (HCC). There are some reports that sorafenib in combination with other modalities, such as transcatheter arterial chemoembolization (TACE) or radiation therapy, co...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Int Surg
Główni autorzy: Nakamura, Kenichi, Beppu, Toru, Hayashi, Hiromitsu, Okabe, Hirohisa, Imai, Kastunori, Nitta, Hidetoshi, Chikamoto, Akira, Ishiko, Takatoshi, Sasaki, Masato, Baba, Hideo
Format: Artigo
Język:Inglês
Wydane: The International College of Surgeons, World Federation of General Surgeons and Surgical Specialists, Inc. 2015
Hasła przedmiotowe:
Hepatobiliary & Pancreatic Surgery
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4452982/
https://ncbi.nlm.nih.gov/pubmed/26011214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9738/INTSURG-D-14-00133.1
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy